Advertisement

Improving Access to Treatment for PIDD in Minority/Underserved Populations

, | January 21, 2022

Improving Access to Treatment for PIDD in Minority/Underserved Populations

This podcast is supported by Pfizer.

The third of three podcasts will outline barriers to immune globulin and transplantation and offer solutions for patients with Primary Immunodeficiency Disorders (PIDD).

The miniseries is hosted by Gerald Lee, MD, an allergist/immunologist at Children’s Healthcare of Atlanta, Atlanta, GA. He is currently an associate professor of pediatrics and internal medicine at the Emory University School of Medicine where he is director of the medical school’s immunology thread and director of the allergy/immunology fellowship. He is an assistant editor for Allergy Watch and co-hosts the ACAAI AllergyTalk podcast. Joining him are Vivian Hernandez-Trujillo, MD, director of the Division of Allergy and Immunology, and Fellowship training program director for Allergy and Immunology, Nicklaus Children’s Hospital, Miami, FL; and Carla Davis, MD, chief of the Immunology, Allergy, and Retrovirology Section of the department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital and the Janie and Sandra Queen Endowed Chair on Immunology and HIV/AIDs, Houston, TX.

We’re pleased to introduce CME credit for this episode of AllergyTalk! Get credit for this episode.

ACAAI presents this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to the procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that may be referenced.

Advertisement